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Wee is a Scottish word meaning of small size, i.e. this is a “small” book 
about PDT
Introduction
The aim of this “wee” book is to give a short overview on photodynamic 
therapy (PDT) for the skin, for example when used to treat sun damage or 
skin cancer. PDT can also be used to treat a wide range of cancers and pre-
cancers in other organs, from the bowel to the brain. 
PDT is unusual as it uses light to trigger a chemical reaction in skin. 
Before this can happen, a special cream containing a drug is applied to 
the diseased part of the patient’s skin making this area more sensitive to 
light. Performing the therapy in a hospital is reasonably straightforward 
but the underlying mechanisms of the chemical reaction are complex. A 
wide-range of specialists have been involved in researching and delivering 
this therapy, which involves physics, biology, chemistry and medicine. We 
bring these specialisms together in this book, to explain in understandable 
language how the treatment works, breaking down the science that 
underpins this fascinating therapy. 
Who are we?
We are a group of doctors and scientists, spread across 
a wide range of institutes in the east of Scotland. 
•	 Doctors, medical physicists, clinical technologists, 
biochemists and nurses from NHS Tayside; 
•	 Doctors, engineers and physicists from the University 
of Dundee; 
•	 Astronomers and physicists from the University of St 
Andrews. 
We have all come together at various stages to work with the Scottish 
Photodynamic Therapy Centre (SPDTC). The centre was established in 
2001 and is supported financially by the Alfred Stewart Trust, a charitable 
organisation which was established by property developer Alfred Stewart 
in his Will to fund or support medical research and other charitable 
activities. The goal of the SPDTC is to promote the use, research and 
development of PDT. This “wee” book is made possible by funding from a 
Science and Technology Facilities Council Impact Accelerator Award. n
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Of Greek origin, outer most layer of the skin. “epi” meaning over and 
“dermis” meaning skin.
Skin Cells 
Skin is the body’s largest organ and is made up of several layers 
(Figure 1). In the Basal layer, at the bottom of the Epidermis, two 
types of skin cells are made, Keratinocytes and Melanocytes. 
Keratinocytes form most of our skin cells and one of their main 
purposes is to create an environmental barrier, protecting us against 
a variety of dangers such as infections, heat, dehydration and 
radiation from the sun. In the early stages of their life cycle, 
keratinocytes are often referred to as Basal cells however as they 
mature, migrate and change shape they become Squamous cells. 
Melanocytes are responsible for producing melanin, which gives us 
our skin colour.













    Keratinocyte
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Life of a Keratinocyte
▶ Figure 2. Life Cycle of a Keratinocyte. “Adapted from: https://smart.servier.com/category/
medical-specialties/dermatology/”
We can see and touch the 
dead cells in the Stratum 
Corneum. The cells are 
physically harder and will 
eventually fall from the skin 
surface. 
In the Stratum Granulosum 
cells form a watertight 
barrier that helps prevent 
dehydration in the lower 
Spinous layer. Cells above this 
layer receive no nutrients.
Squashed as they travel 
through the Stratum 
Spinosum. This stops them 
from splitting and the cells 
can no longer replicate.
Produced by stem cells in 
the Basal layer. At this stage 





















































We can see and touch the 
dead cells in the Stratum 
Corneum. The cells are physi-
cally harder and will eventually 
fall from the skin surface. 
In the Stratum Granulosum 
cells form a watertight barrier 
that helps prevent dehydration 
in the lower Spinous layer. 
Cells above this layer receive 
no nutrients.
Squashed as they travel 
through the Stratum Spi-
nosum. This stops them from 
splitting and the cells can no 
longer replicate.
Produced by stem cells in 
the Basal layer. At this stage 




The first stage in the life 
cycle of a skin cell is growth, 
where the cell increases in 
size. Then it copies its DNA 
(deoxyribonucleic acid – 
carrier of our genetic code), 
prepares itself to divide before 
finally splitting, creating two 
identical cells. If the DNA in 
your cell is damaged, one of 
three things can happen: 
1. It can repair itself and 
continue its life cycle.
2. It can determine that 
the damage is too severe 
and destroy itself.
3. It can mutate, copying 
the damage and 
continuing its life cycle 
with altered DNA, which 



























Healthy Cell ReproductionA Cancer Cell ReproductionB
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Although your skin protects you from a lot of environmental dangers 
it is still possible for cells in the Basal layer to be harmed (Figure 3). If 
a keratinocyte becomes damaged in the Basal layer there is a small 
chance that it might become mutated and then split to produce more 
mutated cells and an accumulation of the DNA damage. The longer 
these cells remain in the Basal layer, the more they split, and the more 
modified keratinocytes can form. Over a period of years, the likelihood of 
these mutations taking place increases and eventually if there are lots of 
mutated cells, affected areas of the skin can be identified as being pre-
cancerous or cancerous. 
Ultraviolet radiation 
Our main natural source of UV radiation is the sun (Figure 4). Although 
we often think of the sun as being yellow, it emits a broad range of 
radiation known as electromagnetic radiation. This includes every visible 
▶ Figure 3. 
Damage to DNA 
from ultraviolet 
radiation.
Ultraviolet (UV) radiation from the sun can penetrate through 
the skin and reach the Basal layer, damaging the skin cells.
UVC has the highest energy but due to absorption in the atmosphere 
it does not reach the Earth’s surface. Both UVB and UVA however have 
a direct effect on us, penetrating our skin and reaching the Basal layer. 
UVA accounts for almost all (95%) of the UV radiation from the sun 
that reaches Earth and UVA penetrates deeper into the skin than UVB. 
However, UVB is much more (between 1,000 and 10,000 times more) 
effective at causing sunburn and, due to its higher energy, is also more 















colour as well as radiation that we cannot see, including UV radiation. 
Scientists have split UV radiation into three categories (UVA, UVB and 
UVC) corresponding to different energy ranges.
▶ Figure 4. Solar 
Spectrum. Only 
3% of the Solar 
Spectrum is UV 
radiation but this 
small amount 
can cause a lot of 
damage.
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The amount of UV radiation 
reaching your skin depends 
on a number of things:  
1. Location: UV 
radiation levels 
increase closer to the 
equator and at higher 
altitudes. 
2. Seasons: in general 
UV levels are higher 
in the summer than 
the winter, with UVB 
demonstrating larger 
seasonal variation than 
UVA. 
3. The surrounding 
environment and time 









a. Over 90% of UV can penetrate light cloud.
b. Clean snow refects up to 80% of sunburning UV.
c. 60% of UV is received between 10am and 2pm daily.
d. UV levels increase by 4% for each 300 metre increase in 
altitude.
e. Indoor workers receive 10% to 20% of outdoor workers yearly 
UV exposure.
f. Shade can reduce UV levels by 50% or more.
g. White sand reflects up to 15% of UV.
h. At half a metre depth UV is still 40% as intense as at the 
surface.
▶ Figure 5. 
If you are concerned about a mark that you have that has 
changed or has just appeared on your skin, particularly if it 
has changed size, shape or colour, or has started to cause 
you discomfort, then seek advice from your doctor urgently. 
The doctor will examine the skin, looking at characteristics 
such as size, shape, colour and texture of any mark. They may 
also remove a small sample of skin (known as a biopsy) and 
send it to a laboratory to be examined under a  microscope.
In this chapter we will summarise some of the pre-cancerous and 
cancerous skin diseases, which can result from solar UV radiation 
causing DNA damage and mutations in keratinocytes. These are known 
as non-melanoma skin cancer (NMSC). Melanoma, the most aggressive 
form of skin cancer, is the result of mutations in melanocytes and will 
not be covered here as melanoma is not treated by PDT.
Chapter 3: 
Sun-damaged skin
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Actinic Keratosis (AK)
Definition: Actinic keratosis (plural keratoses) 
Known as AK, comes from the Greek “actinic” due to the sun and 
“keratosis” a thickening of the skin. 
▶ Figure 6. Large area coverage of AK on the scalp of a bald man, which is a typically sun 
exposed part of the body.
l Risk increases 
with age
l More common in men 
than women
l Bald men at 
particular increased risk
l More common in 
lighter skin 
types
▶ Figure 7. Facts about AK
AK affects 25% 
of people over 
the age of 60 in 
the UK.
AK affects 60% of 
people over the age of 
40 in Australia.
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▶ Figure 8. There is a small risk that AK can transform into more dangerous squamous 
cell carcinoma (SCC), which can be invasive and spread to other parts of the body 
(metastatic) if it isn’t treated.
Generally AK are fairly harmless and are characterised into 3 
grades:
1. Grade I mild AK. Tend to be felt rather than seen but can 
resemble a honeycomb pattern on the skin. They feel rough 
with a sandpaper like texture. 
2. Grade II moderate AK. These are red and scaly lesions that 
can look like warts.
3. Grade III severe AK. These cause severe thickening of the 
skin. They are raised hard warty lesions that tend to have a 
noticeable honeycomb pattern and feel hard and craggy to 
the touch.
AK SSC
It is thought that people with numerous areas of AK have a 10% chance of 
developing a skin cancer, called a squamous cell carcinoma (SCC) within 
10 years of their AK appearing (Figure 8). This is why AK are usually actively 
treated even though, in their usual form, they are generally harmless. 
AK usually occur as a result of years, or even decades, of exposure to 
ultraviolet radiation from the sun. The damage caused can’t be fully 
reversed and so while it is possible to treat AKs they will often reappear 
after treatment or new ones will develop (sometimes they also just 
disappear without any treatment). A long-term approach to managing 
AKs is needed because overall the treatment costs to the healthcare 
service are high. An important part of managing AKs is raising awareness, 
so that sun exposure is limited in the early years of life which will reduce 
lifetime UV exposure and sun damage and hopefully limit the number 
of future AKs. Using sunbeds, working outdoors and even your genetic 
makeup (for example if you burn easily) can increase the risk, although 
AKs are not hereditary. Other contributing factors for AK formation are 
immunosuppression (this includes people who take immunosuppressive 
drugs e.g. organ transplant patients) as well as individuals with human 
papillomavirus (HPV).
Bowen’s Disease
Bowen’s disease (also referred to as SCC in situ) is an early form of SCC – 
there are cancerous skin cells present but they are ‘in situ’, which means 
they are on the surface and haven’t spread deeper into the skin. Bowen’s 
disease usually presents as red, scaly patches on the skin and this can be 
confused with psoriasis or eczema. (Figure 9). If Bowen’s disease is left 
untreated, there is a small chance that it can spread deeper into the skin 
becoming an invasive SCC. However, most Bowen’s disease does not go 
on to this type of invasive skin cancer.
Chapter  3 Chapter  3
Bowen’s disease typically forms on sun-exposed skin, although lesions 
can also occur on covered sites such as the genitals. The commonest site 
is the lower legs of elderly women. Bowen’s disease does appear to be a 
consequence of long-term sun-exposure and like AK, it is more likely to 
occur in individuals that are immunosuppressed or have HPV. Bowen’s 
disease is not hereditary. 
▶ Figure 9. Bowen’s disease lesion on the arm 
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▶ Figure 9. A close-up (top) and a dermoscope image (bottom) of the same lesion.
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Squamous Cell 
Carcinoma (SCC)
Squamous Cell Carcinoma (SCC) is an invasive NMSC and like the diseases 
already mentioned, it is primarily caused by long term exposure to UV 
radiation from the sun (Figure 10). Although SCCs typically occur on 
sun-exposed areas of the skin, they can form anywhere on the body. As 
mentioned earlier, SCCs can also develop from pre-existing AK or Bowen’s 
disease.
Exposure to the sun, being male, 
genetic makeup particularly sun 
sensitivity skin type, immuno- 
suppression such as in organ 
transplant patients, and people 
with genetic diseases that 
predispose them to skin cancers 
(e.g. albinism and xeroderma 
pigmentosum) are all factors 
which increase the risk of 
developing SCC. Fortunately, SCCs 
may be fairly slow growing and, 
when caught early, are usually 
easily treated. They normally 
appear as a crusty/scaly growth 
where the skin forms a red, raised, 
firm lump. The area can be painful and tender, the surface can break down 
and can sometimes bleed if bumped or scraped. Appearances can also 
vary, and SCC can turn to an ulcer. If left untreated, SCC will spread into 
different tissues in the body through the lymph glands or blood, forming 
secondary deposits of cancer (metastasise).
▶ Figure 10. SCC on the leg
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Basal Cell Carcinoma (BCC)
Basal Cell Carcinoma (BCC) is the commonest cancer in Caucasians 
and is by far the commonest form of skin cancer. It originates from 
cells in the epidermis although the exact cells involved are not as 
clearly understood as for SCC. Long-term UV exposure is a major 
risk factor for BCC which typically occurs on sun-exposed areas. 
Other risk factors are the same as for AK, Bowen’s Disease and SCC. 
Immunosuppression and HPV are not thought to be risk factors for 
BCC. Whilst they are not usually hereditary there are rare genetic 
conditions such as Nevoid BCC syndrome (Gorlin-Goltz syndrome) and 
xeroderma pigmentosum (XP) which drastically increase the risk of 
BCC.
BCCs vary in appearance and can be nodular (lumpy) or a scaly flatter 
red mark (Figure 11). They can appear as a scab that continually bleeds 
▶ Figure 11. Nodular BCC on the nose (left) and superficial BCC on the lower back (right).
Chapter  3  Chapter  3
but does not heal and, if left untreated, an ulcer can form. BCCs are 
usually diagnosed by their appearance as they often have a raised 
rolled pearly edge, seen best when the skin is stretched. Skin biopsies 
may be performed. BCCs characteristically do not spread to other 
body parts, although they can destroy important cellular structures 
through invasive growth locally if they are left untreated. They can 
usually be treated easily although it becomes more complicated 
when they occur at risky body sites (such as the eyes, ears and nose) 
or when they are left untreated for a long time. BCC is only very rarely 
fatal; this happens if left untreated. It is very likely that if someone 







•	 BCC	 are	 often	 called	 “rodent	 ulcers”	 because	 they	
gradually	 destroy	 the	 skin	 going	 deeper	 into	 its	
structure,	 like	 a	 rodent,	 and	 if	 left	 untreated	 can	
cause	an	ulcer
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It is essential to overview all the treatment options available and 
it is important to have choice as what might suit one person may 
not be ideal for another. 
Treatment for skin cancers and pre-cancers mentioned previously 
fall into two categories:
1. Lesion directed – treatment of a single small area of diseased skin. 
Examples include surgery and cryotherapy.
2. Field directed (can also be used as lesion directed treatments) – 
treatment of a larger field of skin that includes several areas of skin 
pre-cancer and/or cancer within it.. Examples include applying drugs 
in the form of creams to the skin and, the focus of this book, PDT. 
Chapter 4: 
Treatment for sun 
damaged skin & NMSC













▶ Figure 12. Scar on the left shoulder resulting from surgery. A BCC is visible beside the scar
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treatment, which may last for several weeks and can be difficult for 
patients to tolerate. 
• If not applied properly or regularly then there may be a less effective 
outcome, so it is dependent on the patient or their carer being able 
to treat themselves.
Imiquimod
• Triggers an immune response at the treated site, adapting the 
skin’s immune system to recognise and react against diseased 
tissue resulting in inflammation and destruction of abnormal 
cells. 
• Typically applied to the affected area as a thin lotion 3 days a 
week, at night, allowing it to absorb into the skin for 8 hours 
before being washed off the following day. This treatment regime 
continues for 4 weeks for AK. If used for superficial BCC then it 
will be applied 5 times a week for 6 weeks..
Diclofenac gel
• Nonsteroidal anti-inflammatory gel that is only used to treat AK.
• It is applied as a gel to the sun-damaged area, twice daily, for 60 to 
90 days. 
• As with the other topical drugs, there may be side effects with this 
treatment, which include inflammation and discomfort, although 
these are usually minor.
Other
• Radiotherapy may occasionally be used to treat invasive NMSC 
such as SCC, particularly when surgical options are not possible. 
The tumour is exposed to ionising radiation in a controlled 
procedure and is done over the course of numerous treatments.
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▶ Figure 13. PDT being performed on a lower leg.
•	 Very uncommonly NMSC, particularly invasive SCC, can metastasise 
to other parts of the body and then chemotherapy may be needed - 
as is the case for other types of metastatic cancer.
Photodynamic Therapy (PDT)
PDT is an effective treatment for either single lesions or for large 
treatment areas of pre-cancerous sun damage changes (AK and 
Bowen’s	disease)	and/or	certain	types	of	NMSC,	particularly	superficial	
BCC. It is different from all the other treatments mentioned thus far as 
it uses not just a drug, but also light and oxygen to kill the diseased cells 
(Figure 13). n





Of Greek origin, means “light” when it is combined with another term to 
form a word. For example, photography which is a light (photo) drawing 
(graphy). 
Background
In 1900, medical student Oscar Raab discovered during a thunderstorm 
that certain drugs would interact with light and kill cells. Oscar Raab’s 
mentor Professor Hermann von Tappeiner (a skin specialist who came up 
with the term photodynamic therapy PDT) started experimenting with  
these drugs on the skin and, with a white light, successfully treated some 
skin cancers. He showed that when used on their own both the drug 
and the light were harmless. However, when added together, and in the 
company of oxygen, damaged cells could be destroyed (Figure 14). 
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PDT for precancerous skin 
changes and non-invasive 
NMSC is a straightforward 
treatment to perform 
and receive - a cream 
containing the drug is 
applied to the skin in the 
area to be treated, there 
is a period of waiting and 
then a light is shone on the 
area. 
Drug
For PDT of the skin, a 
cream containing a 
prodrug is used. There are 
two common types of prodrug:
1. 5-aminolaevulinic acid (5-ALA) 
2. methyl aminolevulinate (MAL) 
The prodrug (cream) is absorbed by the skin and changed by the skin 
cells into a chemical that is sensitive to light, known as a photosensitiser. 
The uptake and conversion processes happen more quickly in 
cancerous cells, resulting in more photosensitiser in the tumour than 
in the surrounding normal skin. The photosensitiser remains in the skin 
cell until it is either activated by light or is changed further by the cell 
(see next section). The photosensitiser cannot be transferred to other 
cells which means the light sensitive area is restricted to where the 
cream has been applied. Typically, the prodrug (cream) will be left on 







▶ Figure 14. PDT requires 
three critical components 
to work – a photosensitiser 
(drug), light and oxygen.
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How is the prodrug changed into a 
photosensitiser? 
The conversion process in the skin cells, which changes 
the prodrug into a photosensitiser, is known as the “haem 
cycle” and is the main process in haemoglobin metabolism. 
It is a natural process in a cell that takes certain acids 
and converts them into light sensitive chemicals 
called porphyrins. Iron from the body is then added to 
change the porphyrins into haem – the red substance 
in blood that transports oxygen. When extra acids (e.g. 
5-aminolaevulinic acid) are introduced to the skin cells 
from the prodrug they are converted into porphyrins by the 
same natural process described above. However, the next 
stage in the metabolism, adding iron, is a slow process and 
it can’t cope with these extra porphyrins so they build up in 
the skin. In particular there is a build-up of one porphyrin - 
protoporphyrin nine (known as PpIX). 
HaemPp-IX. . .Acids
HaemPp-IX. . .Acids+ extra5-ALA
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Light
When light shines on skin that is full of light sensitive PpIX, the light 
energy is absorbed. This makes the PpIX excited, which it doesn’t like, 
and it wants to get rid of the extra energy it now has. But what does the 
excitation process look like and how does it get rid of the energy?
History
In 1911, Ernest Rutherford proposed a theory for the structure of 
an atom. In 1913 Niels Bohr proposed his model, that built on 
Rutherford’s, describing the structure of a hydrogen atom (Figure 15). 
Here, Bohr depicted a solar system type arrangement where there 
was a tight positive core (i.e. the Sun) and electrons orbiting around 
it (i.e. planets). Later advancements in quantum mechanics showed 
fundamental errors in this theory however the Bohr model is an 
effective method to describe 
how electrons travel through 
different energy levels that 
occur within atoms. 
Energy Levels
Energy levels in an atom 
appear like rungs on a ladder, 
with the ground being the 
lowest energy level, known as 
the ground state. Each step up 
on the ladder requires more 
energy than the previous step. 
The photosensitiser PpIX has 
electrons on the ground level 
and external energy must be 
l electron orbitl proton
l electronl neutron
▶ Figure 15. An example of Bohr atomic model
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absorbed to move an electron out of the ground level. In PDT, this is 
achieved by using light of a specific energy (at least the same as the 
energy of our first level) to excite the electron onto a higher energy 
level (Figure 16). 
▶ Figure 16. Incoming light provides energy that moves an electron from its ground state 
to the first excited level.
When the photosensitiser absorbs the light energy, it moves onto the 
first excited level leaving behind a hole in the ground level. However 
the first excited level is not the only excited level in which an electron 
can exist - there are additional higher energy levels further up the 
ladder. There is also a forbidden transition, known as the triplet state 
(Figure 17). The triplet state can be thought of as another energy 
ladder that shares the ground level with the first energy ladder.
Excited electrons don’t like having extra energy, they want to lose 
it and return to the ground level which they can do in two different 
ways. The first is called non-radiative, energy is lost by emitting heat 
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or vibrating. The second is called 
radiative, where energy is lost 
by emission of light. The light 
that is emitted has less energy 
than the light that was originally 
absorbed. The process that 
allows electrons to switch from 
the 1st excited level to the lower 
energy forbidden triplet state, is 
known as intersystem crossing 
and is non-radiative. 
For PDT we want the excited 
PpIX electrons to be in the 
forbidden triplet state because 
this allows time for the energy to 
be transferred to the third and 
final component required for 
PDT - oxygen. 
Protoporphyrin-IX
PpIX prefers to absorb blue light (Figure 18) but it can 
also absorb other energies of light too (light with 
different energies appear to our eyes as different 
colours). Red light is used for most PDT for NMSC, it isn’t 
as efficient as blue light but travels deeper in the skin to 
reach damaged cells. Blue light or white light can also 
be used to treat AK, as these damaged cells are located 
in only the most superficial parts  of the skin.
▶ Figure 17. The triplet state and 
intersystem crossing.
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▶ Figure 18. Protoporphyrin-IX absorption curve.
Oxygen
Oxygen is vital for our cells. Once we breathe in oxygen it enters 
our lungs and is transferred to our blood. It is then sent to the heart 
which pumps the oxygenated blood around our bodies. The cells 
of our bodies (including our skin cells) are supplied with oxygen 
from this blood but skin is also supplied with oxygen from the 
atmosphere, creating a large available quantity. 
As described already, intersystem crossing allows some of the PpIX’s 
electrons to be in an excited triplet state when light is being shone 
on the treatment area. Excited PpIX wants to transfer its energy to 
something else, where the ‘something else’ in this case is oxygen. It 
does this in two ways, called a type 1 or type 2 reaction. Both cause 
stress and damage to our cells but type 2 is the preferred reaction 
for PDT. As the PpIX transfers its energy to oxygen, there is enough 
energy from the PpIX to excite the oxygen into its first excited 
state, in oxygen’s own ladder. This creates singlet oxygen which is 
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extremely toxic to living cells. As the singlet oxygen, which is in an 
unstable excited state, transfers back to its ground state it releases 
its energy causing cell death and destroying the diseased tissues 
(Figure 19). The photodynamic therapy process is complete!  
▶ Figure 19.  Exciting oxygen.
Fluorescence 
When violet light is shone onto a photosensitised lesion, 
the lesion emits red light (glows red), which is known 
as fluorescence (Figure 20). Fluorescence is an example 
of radiative energy loss – the light being emitted (red) 
has lower energy than the light used to excite the 
photosensitiser (violet)  n
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▶ Figure 20. BCC under normal lighting conditions (top) and illuminated by violet light 
(bottom). The violet light is absorbed by the PpIX in the BCC and electrons are moved into 
the first excited level. This isn’t stable and they get rid of their energy by releasing red light 
(fluorescence).
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Broadly speaking there are two different PDT techniques commonly 
used to treat pre-cancerous skin changes and superficial NMSC. These 
are known as Conventional PDT and Daylight PDT.
Conventional PDT
Conventional PDT is currently used to treat: 
• Actinic Keratosis (AK) 
• Bowen’s Disease (BD)




changes & superficial 
non-invasive NMSC
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For AK a single treatment is performed and for Bowen’s disease 
and BCC a second treatment is performed one week after the 
first treatment. The area is reviewed at 3 months by a healthcare 
professional and the process repeated if diseased skin remains.
1. Once a patient arrives at 
their treatment centre the 
area of skin that is going to 
be treated will need to be 
assessed and prepared
2. Crusts and scales on the skin are 
removed by gentle scraping, usually with 
a disposable instrument that looks like 
a mini ice cream scoop (this is called 
curettage). This doesn’t need any local 
anaesthetic as the procedure is not too 
uncomfortable. The scraping roughens 
the skin and allows better absorption of 
the prodrug.
3. The prodrug is applied to the 
affected area, normally with a 
spatula or gloved finger. A small 
border of normal skin surrounding 
the treatment area also has the 
prodrug applied to make sure all of 




changes & superficial 
non-invasive NMSC
3 8   The  Wee  Discovery  Book  o f  PDT  The  Wee  Discovery  Book  o f  PDT  3 9
Upon returning to the treatment centre, the dressings are removed, 
and the prodrug wiped off. A lamp is positioned over the treatment 
area, which is then illuminated with a bright red light (Figure 
21). As previously described the light energy is transferred to the 
photosensitiser, which in turn passes the energy to oxygen and the 
resulting energy release in oxygen destroys the damaged cells. The 
light will stay on until enough of the light’s energy has been absorbed 
by the photosensitiser. Typically this takes between 5 and 20 minutes. 
Treatment is finished once the light is switched off. 
4. Once the cream application is complete the areas are 
then completely covered with dressings so that no light 
reaches them. This is referred to as occlusion. During 
occlusion the prodrug is being taken up and converted 
by the damaged cells into the 
photosensitiser PpIX, and is 
accumulating so that there is lots 
of it available.  The patient can 
normally leave the clinic at this 
point, returning 3 hours later.
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▶ Figure 21. PDT being performed on the back.
The light 
The most common light used for PDT in skin is red LEDs 
(light emitting diodes). Red is chosen because of its ability 
to penetrate further into the skin than higher energy 
colours such as green or blue. Red LEDs are very efficient 
and can produce a lot of energy over a reasonably large 
area, allowing them to treat multiple nearby locations 
at once. Laser light can also be used as can filtered white 
light, but these are far less common. 
Daylight PDT 
Daylight PDT is like conventional PDT but with a few key differences. 
First is that daylight PDT is only used to treat AK. It is somewhat ironic 
that the AK are caused by the sun (the ultraviolet radiation part) and 
can also be treated by the sun (although this time it’s the visible light). 
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1. Upon arriving at the treatment centre, a 
nurse or healthcare professional will assess the 
area requiring treatment and then apply a 
sunscreen to all the patient’s sun exposed sites. 
Sunscreen is specifically chosen so that it does 
not interfere with treatment but does block the 
sun’s UV radiation. Careful sunscreen choice is 
essential as some sunscreens will block some 
of the visible light that is required for PDT and 
can reduce the amount of light the patient 
receives during treatment.
2. After 10 minutes 
crusting and flaky skin 
is removed from the AK 
(using same methods as 
for conventional PDT)
3. The prodrug is 
applied but the treatment 
area is not occluded.
4. Within 30 minutes the patient 
goes outside and exposes the 
treatment area to direct, natural 
daylight for at least 2 hours. What 
they do during that time is up to 
them. Some garden while others 
walk the dog or sit (outside) at a café.
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5. After 2 hours the patients wash the 
area that the prodrug was applied to 
and either cover it up with clothing or 
stays indoors.










▶ Figure 22. Before (left) and after (right) hospital-based  PDT shows an excellent 
cosmetic outcome.
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Side Effects
As with all treatments, there are some known side effects which can 
occur with PDT, although some are less of a side effect and more of a 
positive treatment response as they indicate that the desired reaction 
has taken place. 
•	 Inflamed	skin	–	red,	swollen	and	tender	(Figure 23). 
This is the consequence of the photodynamic reaction and shows 
that treatment has occurred. 
Happens frequently, starts immediately after treatment and 
usually clears within a few days, although. can occasionally last 
longer. 
•	 Pain	during	treatment	(Conventional	PDT)
The photodynamic reaction causes pain.
Higher pain levels experienced when: 
▶ treating large areas
▶ treating the face or scalp and AK 
▶ using intense light sources
Particularly problematic when treating AKs on the face or 
scalp with conventional PDT, which is why nearly painless 
daylight PDT has effectively replaced conventional PDT for AK.
As the factors that are associated with pain are now well 
known, it is very rarely a treatment-limiting problem with PDT.
•	 Allergic	skin	reaction
Rare, estimated at approximately 1 – 2% of patients
Higher risk if large areas being treated several times
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▶ Figure 23. Red, swollen and tender skin immediately after PDT.
Other Factors
It is really important to assess the specific needs of each 
patient individually. One size does not fit all! PDT is often preferred 
to surgery because it doesn’t leave a scar and surgery would not be 
possible for large areas of sun damage. PDT may also be 
preferred to 5-FU and Imiquimod because there isn’t a requirement to 
apply treatment at home regularly for several weeks. 
However, there are factors to consider before providing or receiving 
PDT. 
Conventional PDT takes time to deliver and is repeated a week later for 
non-invasive NMSC, with potential for further treatment in 
three months if not clear. Daylight PDT is more time efficient and 
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can be performed in the home setting, but is only appropriate 
for AK. There is a 2-hour exposure to daylight required but many 
who undergo this therapy enjoy the outdoor treatment 
period. 
The obvious potential downside to ‘daylight’ PDT is that it needs 
reasonable weather conditions. It can’t be raining and it can’t be too 
cold, which usually limits treatment in the UK to months between 
April and October. Planning an appropriate treatment day can 
be challenging, but a bright day will always have enough light for 
treatment within a 2-hour period and if we can do it successfully in 
Scotland then it should be manageable in most other locations.
Various research groups are trying to find ways to be more accurate 
with the light exposure by using wearable light detectors or satellite 
images. In the future this might help reduce the length of the 
treatment but at the time of writing the recommendation remains a 
standard 2 hours of daylight.
Expanding on daylight 
Daylight PDT is typically administered between April 
and October in the UK. The reason for excluding winter 
months is not due to light levels being too low but the 
temperature. Daylight PDT is not usually administered 
when temperatures are under 10˚C as this is, based 
on experience, deemed too cold to ensure compliance 
with treatment. The downsides to daylight PDT have 
led to imaginative solutions for overcoming the 
challenges, for example with temperature control 
such as conservatory-based PDT (Figure 24). 
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Chapter 7: 
What else is PDT 
used for?
At the time of writing, the British Association of Dermatologists 
state that PDT should be considered for prevention of future NMSC 
in high risk patients, such as organ transplant recipients. It should 
also be considered for some pre-cancerous genital conditions, 
treatment resistant warts, as an option for acne and as an anti-
microbial treatment. Whilst PDT has been investigated in a lot of 
other conditions there is, as yet, not enough evidence to support PDT 
for many of these diseases, including  alopecia, hypertrophic scars, 
rosacea and wound healing. There is good evidence that current PDT 
approaches are not effective for psoriasis and should not be used for 
this purpose.
PDT is gaining popularity in the private sector as it is believed to have 
a rejuvenating effect on the areas of skin it is applied to, making 
the area look and feel younger, removing fine wrinkles, and being 
The glass in the conservatory filters out harmful UVB, 
allows in the visible light to perform the treatment 
but also allows temperature to remain constant and 
comfortable. This means when its bright but cold outside, 
treatment can still take place inside. 
Another area of research is the creation of light sources 
that mimic the sun, allowing patients to remain indoors 
for their treatment. Wearable technology for PDT, fibres 
that are woven into sheets with red light passing through 
them, are also now available. Effectively the patient is 
wearing clothes that ‘glow’ red. These fibres are placed 
over the diseased areas, after prodrug application, and 
are left to illuminate the area for a time until a certain 
amount of light is delivered.  n  
▶ Figure 24. Conservatory based PDT
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of time varying and depending on the photosensitiser used. Many of 
the photosensitisers used in the past were not specific enough and 
lasted in the body for a prolonged period. This meant the person was 
sensitive to light often for many weeks after the photosensitiser was 
given. They would therefore be required to undertake light protective 
measures, such as covering all areas of skin, wearing sunglasses 
and avoiding sunlight or bright indoor lights. The more modern 
photosensitisers have sought to overcome these limitations. 
Getting light to the treatment area can be challenging but is essential 
as this allows accurate and specific treatment of the tumour and this 
is a highly researched area. In general, thin optical fibres, similar to 
those used in telecommunications, are used. These fibres are flexible 
and manoeuvrable allowing them to target difficult to reach areas. 
Light (normally from a laser) travels down the fibre and exits at the 
end, which is either placed inside the tumour or beside it. Several 
fibres can be used at the one time, which allows the treatment of 
larger tumours.  
PDT has been researched for a wide range of different cancers, 
including head, neck and oral cancers, lung cancer, oesophagus 
(gullet) cancer, and pre-cancer (Barrett’s oesophagus), prostate cancer 
and even glioblastoma (brain tumour). Some of the research has been 
in the form of clinical trials but the vast majority has been performed 
in laboratories. At the current time of publication, routine clinical PDT 
is rare for areas other than the skin. However the fluorescence (red 
glow – Figure 20) provided by the photosensitiser is routinely used as 
a guide for the removal of tumour tissue in the brain (glioblastoma 
- Figure 26) and has also been used for diagnosis of bladder cancer 
and pre-cancer. This technique is is known as photodynamic diagnosis 
(PDD) rather than photodynamic therapy (PDT).  n
marketed as an anti-aging treatment. However, there isn’t enough 
evidence available yet to support recommending PDT for this purpose.
Whilst PDT is a routine treatment in dermatology, it is a less 
common therapeutic approach for cancer affecting other organs 
although there is a lot of research in using PDT to treat a wide range of 
cancers. 
PDT for internal diseases
When considering PDT for diseases within the body (often called 
systemic PDT) the underlying processes (light, oxygen, photosensitiser) 
are the same as PDT for skin, 
however there are some 
important differences in 
the way the treatment is 
performed.
For PDT within the body a 
cream cannot be applied 
to the treatment area and 
therefore the photosensitiser 
is delivered as either a drink 
or an injection and there 
is no need for a pro-drug 
phase. The photosensitiser 
will circulate around the 
body and be preferably 
taken up in the cancerous 
cells. The photosensitiser is 
given time to build up within 
the cancer cells – the length 
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In this Wee Discovery Book of PDT, we have given an overview of 
photodynamic therapy in the treatment of pre-cancerous sun damaged 
skin and non-invasive NMSC. We have introduced the skin and its 
structure, explaining how it can be damaged by radiation from the 
sun. This damage can result in a range of different skin pre-cancers and 
cancers and we have provided detailed information of the commonest 
conditions. Whilst there are many treatment options available for these 
pre-cancerous skin lesions and non-invasive NMSC this book focuses on 
PDT, as an effective and often patient preferred treatment. Significant 
side effects are rare and the biggest hurdle, pain, is no longer a 
noteable issue due to the introduction of daylight PDT and low intensity 
irradiation.
PDT is an important tool amongst the available treatment options 
for these conditions. With a large variety of choices available, each 
▶ Figure 26. Fluorescence of tumour tissue in the brain (top) and under normal white-
light illumination (bottom). Image courtesy of medac GmbH.
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with their own advantages and disadvantages, it is possible to find 
the treatment that fits the patient best and to make changes when 
a treatment is not successful. Clinical research continues to see the 
advancement of PDT, improving how effective it is and exploring its use 
for cancers within the body. There is a lot of research across the globe 
investigating these important topics and we predict a bright future for 
this light-drug therapy. 
It is vital that patients should be able to make an informed choice and 
as such there should be numerous sources of information available that 
vary in complexity. For healthcare professionals who are not specialist 
in skin diseases it is also important to have easily accessible information 
which can inform clinical practice. n
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